The first three Parkinson's patients who received ANPD001 saw improvements in motor symptoms and daily functioning, early trial data showed.| Parkinson's News Today
Target enrollment is complete for a Phase 1b trial testing the safety and tolerability of GT-02287 in people with Parkinson’s disease.| Parkinson's News Today
People with Parkinson's can have trouble identifying emotions, an idea that has columnist Mary Beth Skylis looking at her father anew.| Parkinson's News Today
Metabolic syndrome is associated with an increased risk of dementia among people with Parkinson's disease, according to a study from Turkey.| Parkinson's News Today
In her debut, columnist Mollie Lombardi describes her early collection of symptoms and how she discovered what they meant: Parkinson's.| Parkinson's News Today
In his debut column, Chukwuemeka Uchebuakor describes the importance of the "love factor" in caring for his father with Parkinson's.| Parkinson's News Today
Medical scientists recognize two types of Parkinson's disease: primary parkinsonism and forms known as atypical and secondary parkinsonism.| Parkinson's News Today
The FDA has cleared CAP-003, a gene therapy for Parkinson’s associated with GBA mutations, to be tested in clinical trials.| Parkinson's News Today
Cure Parkinson’s is funding SLEIPNIR, a clinical trial platform that will simultaneously test up to three disease-modifying treatments.| Parkinson's News Today
Routine evaluations and adjustments provide columnist Mollie Lombardi the best results with her deep brain stimulator.| Parkinson's News Today
Michael S. Okun, MD, answers questions about deep brain stimulation for people with Parkinson's in our monthly "Expert Voices" series.| Parkinson's News Today
Read about physiotherapy and exercise programs, done under a specialist's guidance, to help maintain muscle strength and balance in Parkinson's patients.| Parkinson's News Today
Side-to-side eye movements reduced body sway in people with Parkinson's disease in a study of 10 people with Parkinson's and 11 without it.| Parkinson's News Today
Columnist Mollie Lombardi shares how her early-onset Parkinson's disease diagnosis has affected her husband and their marriage.| Parkinson's News Today
Focused ultrasound, a minimally invasive technology, will soon be available at Vanderbilt to treat essential tremor and Parkinson’s disease.| Parkinson's News Today
Columnist Christine Scheer compares her Parkinson's symptoms today with their severity before she had deep brain stimulation surgery.| Parkinson's News Today
While there's no test to confirm a Parkinson's diagnosis in its early stages, the disease can be detected based on a variety of symptoms.| Parkinson's News Today
Columnist Mary Beth Skylis shares tips for positive coping skills that she encourages her dad, who has Parkinson's, to implement.| Parkinson's News Today
The causes of Parkinson's disease can include a combination of genetic and environmental factors. Age and gender may also be risk factors.| Parkinson's News Today
The American Parkinson Disease Association (APDA) has awarded $2.6 million to research projects aiming to better understand Parkinson's.| Parkinson's News Today
The FDA approved a brain mapping tool that will enable doctors to more precisely use neuromodulation therapies like DBS.| Parkinson's News Today
A history of upper gastrointestinal mucosal damage was associated with a 76% greater risk of subsequently developing Parkinson's disease.| Parkinson's News Today
The FDA issued a letter encouraging the use of an alpha-synuclein assay to improve the efficiency of clinical trials in Parkinson's disease.| Parkinson's News Today
UCF researchers have developed a biosensor that can rapidly detect and quantify dopamine levels in unprocessed blood samples.| Parkinson's News Today
Learn about Parkinson's disease, a condition that affects the brain, resulting in issues with movement, balance, and more.| Parkinson's News Today